6-(4-substituted-anilino)pyrimidine derivates, method for preparation thereof and antiviral pharmaceutical composition comprising the same
申请人:Kim Jong-Woo
公开号:US20050222150A1
公开(公告)日:2005-10-06
The present invention relates to 6-(4-substituted-anilino)pyrimidine derivatives useful as an antiviral agent, and more particularly novel 6-(4-substituted-anilino)pyrimidine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus; HCV), represented by the following formula I:
in which R represents a C
1
-C
4
straight or branched alkoxycarbonyl group, heterocycliccarbonyl group or carboxyalkyl group; and pharmaceutically acceptable salts thereof, a preparation method thereof, and an antiviral pharmaceutical composition comprising the compound as an effective ingredient. The 6-(4-substituted-anilino)pyrimidine derivatives according to the present invention have an excellent inhibitory effect on replication of Hepatitis C virus (HCV) and thus can be advantageously used as a therapeutic or prophylactic agent of hepatitis C.
本发明涉及可用作抗病毒剂的 6-(4-取代-苯胺基)嘧啶衍生物,尤其是对丙型肝炎病毒(HCV)的复制具有极佳抑制作用的新型 6-(4-取代-苯胺基)嘧啶衍生物,由下式 I 表示:
其中 R 代表 C
1
-C
4
直链或支链烷氧基羰基、杂环羰基或羧基烷基;及其药学上可接受的盐、其制备方法和包含该化合物作为有效成分的抗病毒药物组合物。根据本发明的 6-(4-取代-苯胺基)嘧啶衍生物对丙型肝炎病毒(HCV)的复制有很好的抑制作用,因此可作为丙型肝炎的治疗或预防药物。